At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Nov 12, 2026 at 16:07 ET
Two NovoCure insiders, including the CFO and CHRO, sold shares in open-market transactions totaling $103K over a one-week period. The sales are small relative to the company's $1.4B market cap (0.007%), making them routine and not indicative of material non-public information.
- CFO Brackmann Christoph sold 7,343 shares at $12.86 for $94K on Nov 9, 2026
- CHRO Puri Michal Nath sold 660 shares at $13.24 for $9K on Nov 2, 2026
- Total open-market sales by insiders: $103K, or 0.007% of market cap
- Neither sale was executed under a 10b5-1 plan
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access